Plasma biomarkers for Alzheimer’s disease: have we found the Holy Grail?


  • A multicenter study has identified a set of inflammatory plasma biomarkers that can distinguish clinical subgroups of Alzheimer’s disease.

Why this matters

  • The search for plasma biomarkers to aid the diagnosis of Alzheimer’s disease (AD) is ongoing; this study reveals potential inflammatory markers that could help identify the disease and predict progression.